Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 桂林三金药业股份有限公司是三金集团的核心企业，主营中成药、天然药物的研发和生产，是国内较早生产现代中药制剂的厂家之一。1985年以来，桂林三金坚持改革创新，依靠科技进步和科学管理，从一个名不见经传的中药作坊小厂蜕变成为全国知名的现代中药企业，跻身中国中药行业50强前列。企业先后荣获全国企业管理杰出贡献奖、全国思想政治工作优秀企业、全国文明单位、全国中药行业优秀企业、国家技术创新示范企业、全国质量标杆、中国质量奖提名奖等荣誉。 桂林三金作为区内外知名的高新技术企业，建有国家认定的企业技术中心、博士后科研工作站及广西中药产业化工程院等创新平台。多年来，一直致力推进和实施中药产业现代化规划，积极培养、提高企业的自主创新能力。公司的特色中药新药均由企业技术中心主导研制。目前，桂林三金拥有200多个注册品种，拥有桂林西瓜霜、西瓜霜润喉片、三金片、脑脉泰胶囊等自主开发的独家特色品种47种。经过多年努力，桂林三金在咽喉、口腔用药和泌尿系统用药方面已形成较强的专业和市场优势，代表产品三金西瓜霜系列、三金片多年稳居全国同类中成药前列。 2009年7月，桂林三金以高成长、高效益的崭新面貌，成功进入资本市场，迎来企业高速发展的新阶段。近年来，为积极响应桂林市委、市政府“向西发展，再造一个新桂林”的号召，也为解决企业生产基地及仓储设施分散与企业快速发展之间的矛盾，桂林三金启动了“三金现代中药产业化技术改造工程”的建设。2015年完成桂林三金现代中药城一期工程建设并投产，开启了二次创业的新征程。 面对未来，桂林三金将秉承“创新推动医药进步”的企业使命和“敢为先”企业精神，实施以中药制药为主体，致力发展生物制药和大健康产业的”一体两翼”发展战略，视质量、信誉为企业第一生命，突破创新，不断增强桂林三金的竞争实力，锐意进取，以发展报国、回报投资者，以打造中国领先的医药制造集团为目标，推动中药产业现代化、国际化!
Main Business 中成药的研发、制造与销售，同时涵盖化学药品制剂、生物制剂与日化保健大健康等多个细分行业
Legal Representative 邹洵
Top Executives
董事长：邹洵
董事：谢元钢,邹准,徐劲前,雷敬杜,付丽萍
独立董事：刘焕峰,何里文,莫凌侠
Top 5 Shareholder
Shareholder name Nature Holding Date
桂林三金集团股份有限公司流通A股62.07%31/03/2024
翁毓玲流通A股4.99%31/03/2024
邹准限售股+流通A股3.87%31/03/2024
谢元钢限售股+流通A股1.30%31/03/2024
邹洵限售股+流通A股1.11%31/03/2024
Company Secretary 李春
Solicitors 北京市通商律师事务所
Auditors 浙江天健东方会计师事务所有限公司
Tel No 0773-5829106;0773-5829109
Fax No 0773-5838652
Website www.sanjin.com.cn
Email dsh@sanjin.com.cn
Company Address
Register: 广西壮族自治区桂林市临桂区人民南路9号
Office: 广西壮族自治区桂林市临桂区人民南路9号
Listing Date 10/07/2009
Shares Capital
Shares Capital: 590,200,000
Total A Share: 590,200,000
Listed A Share: 538,454,600
Non-tradable A Share: 51,745,400
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.720
DPS(RMB)* ¥ 0.600
NBV Per Share(RMB)* ¥ 4.794
Market Capitalization(RMB) 8.099B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.